Transgenic mouse model for estrogen-regulated lipoprotein metabolism: studies on apoVLDL-II expression in transgenic mice

Transgenic mouse model for estrogen-regulated lipoprotein metabolism: studies on apoVLDL-II expression in transgenic mice

We have produced transgenic mice that express an estrogen-responsive avian apolipoprotein, apoVLDL-II. An apoVLDL-II natural gene construct containing 4.7 kb of 5‘ flanking and 19 bp of 3‘ flanking sequences together with the 4 exon/3 intron structural gene was expressed in a liver-specific manner i...

Full description

Bibliographic Details
Main Authors:	E Zsigmond, M K Nakanishi, F E Ghiselli, L Chan
Format:	Article
Language:	English
Published:	Elsevier 1995-07-01
Series:	Journal of Lipid Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520397327

Similar Items

ApoVLDL of the Watanabe Heritable Hyperlipidemic rabbit and the cholesterol-fed rabbit.
by: T Wakasugi, et al.
Published: (1984-03-01)

ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
by: Joan Carles Escolà-Gil, et al.
Published: (2001-02-01)

Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice1
by: Shen Qu, et al.
Published: (2007-07-01)

LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice
by: P.J. Tacken, et al.
Published: (2000-12-01)

Single Nucleotide Polymorphisms of GST CL3, Otrf, FASN, INSIG1, apoVLDLⅡ, and apoB Genes Differentially Expressed in Liver of Taiwan Country Chickens
by: Tzu-Han Chen, et al.
Published: (2008)

Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.
by: K Aalto-Setälä, et al.
Published: (1996-01-01)

Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion
by: Jessica Lie, et al.
Published: (2002-11-01)

Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro
by: Eva Zsigmond, et al.
Published: (1998-09-01)

Reduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic mice.
by: Stephanie M Marshall, et al.
Published: (2014-01-01)

Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo
by: Miranda Van Eck, et al.
Published: (2008-01-01)

Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice
by: Bart J.M. van Vlijmen, et al.
Published: (1998-06-01)

Immunoregulation in the NOD mouse and NOD transgenic mice
by: Thomas, Thomas David Colin
Published: (2007)

Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice
by: Sonia M. S. Espirito Santo, et al.
Published: (2005-06-01)

Introducing Human APOE into Aβ Transgenic Mouse Models
by: Leon M. Tai, et al.
Published: (2011-01-01)

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins
by: Matthias Schneider, et al.
Published: (2005-04-01)

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome
by: Esther M.M. Ooi, et al.
Published: (2012-11-01)

Mouse Genetics Study of the Gret Gene in Transgenic Mice
by: Hui-Wen Zhuang, et al.
Published: (2008)

Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle
by: Leslie K. Pulawa, et al.
Published: (2007-01-01)

Unusual metabolic characteristics in skeletal muscles of transgenic rabbits for human lipoprotein lipase
by: Viglietta Céline, et al.
Published: (2004-12-01)

Very low density lipoprotein (VLDL) metabolism and egg cholesterol in Gallus domesticus
by: Huggett, Christine Diane
Published: (1994)

Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test
by: Wahnschaffe Ulrich, et al.
Published: (2005-01-01)

Proteomic analysis of aortae from human lipoprotein(a) transgenic mice shows an early metabolic response independent of atherosclerosis.
by: Euan J Rodger, et al.
Published: (2012-01-01)

Preβ high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice
by: Ji-Young Lee, et al.
Published: (2004-04-01)

Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis
by: Yuko Kako, et al.
Published: (1999-12-01)

High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice
by: J K Bielicki, et al.
Published: (1997-11-01)

Transcription-dependent silencing of inducible convergent transgenes in transgenic mice
by: Calero-Nieto Fernando J, et al.
Published: (2010-01-01)

Transgenic RNAi in mouse oocytes
by: Sarnová, Lenka
Published: (2009)

Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II
by: Lawrence W. Castellani, et al.
Published: (2004-12-01)

Altered lipoprotein metabolism in transgenic mice expressing low levels of a human receptor-binding-defective apolipoprotein E variant.
by: S. Fazio, et al.
Published: (1994-03-01)

Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2
by: Pia Stillemark-Billton, et al.
Published: (2005-01-01)

Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains
by: Emanuel Voyiaziakis, et al.
Published: (1999-11-01)

Insulin BBB pharmacokinetics in young apoE male and female transgenic mice.
by: Elizabeth M Rhea, et al.
Published: (2020-01-01)

Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice
by: Juan Maldonado Weng, et al.
Published: (2019-12-01)

Tolerance and immunity in transgenic mice
by: Husbands, Sandra D.
Published: (1991)

Characterization of the EDF transgenic mice
by: JUN-JAI LAI, et al.
Published: (2007)

Variegated transgene expression in mice
by: Opsahl, Margaret L.
Published: (2001)

Apolipoprotein VLDL-II inhibits lipolysis of triglyceride-rich lipoproteins in the laying hen.
by: WJ Schneider, et al.
Published: (1990-03-01)

Regulation of very low-density lipoprotein (VLDL) metabolism by dietary fat saturation and chain length.
by: Abdel-Fattah, Ghada Fathy.
Published: (1994)

Lipolytic remnants of human VLDL produced in vitro: effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants
by: Byung Hong Chung, et al.
Published: (2000-02-01)

Human apoB contributes to increased serum total apo(a) level in <it>LPA </it>transgenic mice
by: Teivainen Päivi A, et al.
Published: (2004-05-01)

Cannot write session to /tmp/vufind_sessions/sess_95ftgfq60vaisgtfhcp8f10jf5